Covalon Technologies (CVE:COV) Shares Up 6.4% - What's Next?

Covalon Technologies Ltd. (CVE:COV - Get Free Report)'s share price traded up 6.4% during trading on Wednesday . The company traded as high as C$3.20 and last traded at C$3.18. 65,649 shares changed hands during mid-day trading, an increase of 32% from the average session volume of 49,559 shares. The stock had previously closed at C$2.99.

Covalon Technologies Stock Down 11.9 %

The stock has a fifty day moving average price of C$3.18 and a 200 day moving average price of C$3.24. The company has a debt-to-equity ratio of 3.28, a current ratio of 7.27 and a quick ratio of 6.45. The stock has a market capitalization of C$76.71 million, a P/E ratio of 32.14 and a beta of 0.64.

Covalon Technologies Company Profile

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.